289 related articles for article (PubMed ID: 36060264)
1. FABP4 in obesity-associated carcinogenesis: Novel insights into mechanisms and therapeutic implications.
Liu S; Wu D; Fan Z; Yang J; Li Y; Meng Y; Gao C; Zhan H
Front Mol Biosci; 2022; 9():973955. PubMed ID: 36060264
[TBL] [Abstract][Full Text] [Related]
2. A New Insight into Fatty Acid Binding Protein 4 Mechanisms and Therapeutic Implications in Obesity-Associated Diseases: A Mini Review.
Başarır Sivri FN; Çiftçi S
Mol Nutr Food Res; 2024 Apr; 68(8):e2300840. PubMed ID: 38593305
[TBL] [Abstract][Full Text] [Related]
3. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
Furuhashi M
J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
[TBL] [Abstract][Full Text] [Related]
4. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
[TBL] [Abstract][Full Text] [Related]
5. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
[TBL] [Abstract][Full Text] [Related]
6. White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes.
Chung JY; Hong J; Kim HJ; Song Y; Yong SB; Lee J; Kim YH
Biomaterials; 2021 Dec; 279():121209. PubMed ID: 34700224
[TBL] [Abstract][Full Text] [Related]
7. Role of Fatty Acid Binding Protein 4 (FABP4) in Kidney Disease.
Shi M; Ma L; Fu P
Curr Med Chem; 2020; 27(22):3657-3664. PubMed ID: 30306857
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid binding proteins: tissue-specific functions in health and disease.
Thumser AE; Moore JB; Plant NJ
Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):124-9. PubMed ID: 24500438
[TBL] [Abstract][Full Text] [Related]
9. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.
Thompson KJ; Austin RG; Nazari SS; Gersin KS; Iannitti DA; McKillop IH
Liver Int; 2018 Jun; 38(6):1074-1083. PubMed ID: 29171144
[TBL] [Abstract][Full Text] [Related]
10. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
Furuhashi M; Saitoh S; Shimamoto K; Miura T
Clin Med Insights Cardiol; 2014; 8(Suppl 3):23-33. PubMed ID: 25674026
[TBL] [Abstract][Full Text] [Related]
11. Serum Fatty Acid-Binding Protein 4 Levels in Adolescents: Effect of Insulin Resistance.
González AP; Gutiérrez-Castro KP; Caccavello R; Garay-Sevilla ME; Gugliucci A
Metab Syndr Relat Disord; 2022 Jun; 20(5):295-302. PubMed ID: 35333608
[No Abstract] [Full Text] [Related]
12. Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer.
Sun N; Zhao X
Front Pharmacol; 2022; 13():948610. PubMed ID: 35899119
[TBL] [Abstract][Full Text] [Related]
13. FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3/IL-1β axis.
Yang J; Liu S; Li Y; Fan Z; Meng Y; Zhou B; Zhang G; Zhan H
Cancer Lett; 2023 Oct; 575():216403. PubMed ID: 37741433
[TBL] [Abstract][Full Text] [Related]
14. Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus.
Trojnar M; Patro-Małysza J; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B; Mosiewicz J
Cells; 2019 Mar; 8(3):. PubMed ID: 30857223
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.
Lamounier-Zepter V; Look C; Alvarez J; Christ T; Ravens U; Schunck WH; Ehrhart-Bornstein M; Bornstein SR; Morano I
Circ Res; 2009 Aug; 105(4):326-34. PubMed ID: 19608978
[TBL] [Abstract][Full Text] [Related]
16. Interaction of epoxyeicosatrienoic acids and adipocyte fatty acid-binding protein in the modulation of cardiomyocyte contractility.
Lamounier-Zepter V; Look C; Schunck WH; Schlottmann I; Woischwill C; Bornstein SR; Xu A; Morano I
Int J Obes (Lond); 2015 May; 39(5):755-61. PubMed ID: 25370574
[TBL] [Abstract][Full Text] [Related]
17. FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.
Mita T; Furuhashi M; Hiramitsu S; Ishii J; Hoshina K; Ishimura S; Fuseya T; Watanabe Y; Tanaka M; Ohno K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
Obesity (Silver Spring); 2015 Feb; 23(2):359-67. PubMed ID: 25521833
[TBL] [Abstract][Full Text] [Related]
18. Early increase in serum fatty acid binding protein 4 levels in patients with acute myocardial infarction.
Obokata M; Iso T; Ohyama Y; Sunaga H; Kawaguchi T; Matsui H; Iizuka T; Fukuda N; Takamatsu H; Koitabashi N; Funada R; Takama N; Kasama S; Kaneko Y; Yokoyama T; Murakami M; Kurabayashi M
Eur Heart J Acute Cardiovasc Care; 2018 Sep; 7(6):561-569. PubMed ID: 30178960
[TBL] [Abstract][Full Text] [Related]
19. Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation.
Duffy CM; Xu H; Nixon JP; Bernlohr DA; Butterick TA
Mol Cell Neurosci; 2017 Apr; 80():52-57. PubMed ID: 28214555
[TBL] [Abstract][Full Text] [Related]
20. Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.
Furuhashi M; Hiramitsu S; Mita T; Omori A; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Matsumoto M; Tanaka M; Moniwa N; Yoshida H; Ishii J; Miura T
Lipids Health Dis; 2016 Jan; 15():5. PubMed ID: 26754658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
